Oop's CCSI just announced COMPLETION OF STUDIES FOR NEW MEDICAL APPLICATION IN DERMATOLOGY.
I wonder if she we should lump that under "Chormogenic diseases" or not.
I was interested in a comment from one of the big shorts in the stock this afternoon. He said that insurance companies won't pay for it, and the 2 doctors he spoke don't want it. I am trying to figure that out. What was the letter from the AMA recently, and how does anyone know what the doctors are going to say until we get to New Orleans?
In New Orleans CCSI will be displaying their product to 80% of the MD's from the NICU"s. Neo Natal Intensive Care Units. They will be taking orders for the device then and there. They would like to see the product rolled out to the most important neo-natal hospitals ASAP.
People that have been saying the hospitals don't need it or want it , because it is another expense in a tight fisted market are way off base. What if it cost effective, easier, cheaper, safer, less labor intensive, the equivalent to heel pricks, which it is, and may become the product of choice of the nurses, and doctors. Build it and they will come. Offer it and they will buy.
Some other investors spoke to the company today, and reported that things couldn't be bettter, no problems on the deal, lawyers playing lawyer. Product is ready to be launched on May 1, slightly ahead of SPRX, I believe. |
